Tag:
remediation
Latest Headlines
Latest Headlines
Ben Venue lengthens remediation timeline
Ben Venue Labs is extending the timeline for remediation at an Ohio plant—and along with it the expected availability of some critical drugs currently in short supply. The company made the
Patheon ops 'transformation' aligns with Q4 losses
Contract manufacturer Patheon is "successfully executing on [its] transformation," says CEO Jim Mullen. "In the locations where we have rolled out our operational excellence programs, we have already
Ranbaxy, FDA near $400M deal on longstanding violations
Pesky manufacturing violations appear to be all that's standing between Ranbaxy Labs and its U.S. launch this week of a generic version of Lipitor , Pfizer's ( $PFE ) blockbuster cholesterol drug. The
Hospira plant remediation stings company financials
Hospira ( $HSP ) has taken a big financial hit as a result of manufacturing deficiencies at its Rocky Mount, NC, plant. The hit--more than $1 billion in market capitalization, according to the
Chinese API maker gets stern FDA warning over cross-contamination
Chinese API maker Sichuan Pharmaceutical finds itself on the stinger end of a warning letter just posted to the FDA website. The warning follows two attempts by the drugmaker after a June 2010
Genzyme's shortage opens door to rival Protalix
Manufacturing remediation chugs along at Genzyme , which anticipates some supply constraints of Gaucher-disease treatment Cerezyme before the supply outlook improves in February. Operating under a
